semaglutide fda warning Some people are overdosing on semaglutide, warns | What you should know The U.S. Food and Drug

*In summary, all three medications are effective for managing type 2 diabetes, insulin resistance, obesity and metabolic disorder but tirzepatide appears to be more effective for weight loss

If weekly dose, consider holding the medication for one week before the surgery/procedure. Additionally, the AANA has developed a document, Anesthesia Care of the Patient on a GLP-1 Receptor Agonist, to educate its members on anesthesia care

Employer Case Study: Simplicity and savings for a state employer

For MM+Ms audience, the takeaway is clear: GLP-1 marketing is no longer about persuasion alone

The FDA has approved semaglutide 2.4 mg for metabolic dysfunction-associated steatohepatitis (MASH), a condition in which any alcohol consumption worsens hepatic inflammation